Publicaciones en colaboración con investigadores/as de Instituto de Investigaciones Biomédicas Alberto Sols (22)

2023

  1. Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction

    Biomedicine and Pharmacotherapy, Vol. 158

  2. Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension

    Hypertension, Vol. 80, Núm. 1, pp. 84-96

  3. Trabectedin modulates macrophage polarization in the tumor-microenvironment. Role of KV1.3 and KV1.5 channels

    Biomedicine and Pharmacotherapy, Vol. 161

2021

  1. Graphene Particles Interfere with Pro-Inflammatory Polarization of Human Macrophages: Functional and Electrophysiological Evidence

    Advanced Biology, Vol. 5, Núm. 11

  2. KV1.3 channels are novel determinants of macrophage-dependent endothelial dysfunction in angiotensin II-induced hypertension in mice

    British Journal of Pharmacology, Vol. 178, Núm. 8, pp. 1836-1854

  3. Pharmacological approaches for the modulation of the potassium channel kv4.X and KChIPs

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-21

2019

  1. Corrigendum to Supplemental Material: ‘D242N, a K V 7.1 LQTS mutation uncovers a key residue for I Ks voltage dependence’ [Journal of Molecular and Cellular Cardiology, Volume 110, September 2017, Pages 61–69](S0022282817301633)(10.1016/j.yjmcc.2017.07.009)

    Journal of Molecular and Cellular Cardiology

  2. Identification of IQM-266, a novel DREAM ligand that modulates KV4 currents

    Frontiers in Molecular Neuroscience, Vol. 12

  3. Protective Role of Hepatocyte Cyclooxygenase-2 Expression Against Liver Ischemia–Reperfusion Injury in Mice

    Hepatology, Vol. 70, Núm. 2, pp. 650-665

  4. Targeting the neuronal calcium sensor DREAM with small-molecules for Huntington’s disease treatment

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet

    Journal of Nutritional Biochemistry, Vol. 58, pp. 17-27

  2. PGE2 induces apoptosis of hepatic stellate cells and attenuates liver fibrosis in mice by downregulating miR-23a-5p and miR-28a-5p

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 2, pp. 325-337

2017

  1. Benznidazole, the trypanocidal drug used for Chagas disease, induces hepatic NRF2 activation and attenuates the inflammatory response in a murine model of sepsis

    Toxicology and Applied Pharmacology, Vol. 315, pp. 12-22

  2. D242N, a KV7.1 LQTS mutation uncovers a key residue for IKs voltage dependence

    Journal of Molecular and Cellular Cardiology, Vol. 110, pp. 61-69

  3. IKs computational modeling to enforce the investigation of D242N, a KV7.1 LQTS mutation

    Computing in Cardiology

2016

  1. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1862, Núm. 9, pp. 1710-1723

2015

  1. Hepatic cyclooxygenase-2 expression protects against diet-induced steatosis, obesity, and insulin resistance

    Diabetes, Vol. 64, Núm. 5, pp. 1522-1531

  2. Regulation of microRNA 183 by cyclooxygenase 2 in liver is DEAD-box helicase p68 (DDX5) dependent: Role in insulin signaling

    Molecular and Cellular Biology, Vol. 35, Núm. 14, pp. 2554-2567

2014

  1. PKC inhibition results in a Kv1.5 + Kvβ1.3 pharmacology closer to Kv1.5 channels

    British Journal of Pharmacology, Vol. 171, Núm. 21, pp. 4914-4926

2013

  1. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma

    International Journal of Biochemistry and Cell Biology, Vol. 45, Núm. 11, pp. 2501-2511